← Abbott
Episodes featuring Abbott
34 episodes, newest first.
- Nov 18, 2026
Nvidia rally fades as Target and cybersecurity stocks stand outStock Market Today With IBDNov 18, 2026 - Nov 9, 2026
AbbVie builds a risk-managed neuroscience portfolioBusiness Of BiotechNov 9, 2026 - Nov 3, 2026
Cramer weighs tech’s sell-off against healthcare’s growth caseMad Money w/ Jim CramerNov 3, 2026 - Oct 23, 2026
Lanifibranor faces a pivotal test in MASHBreaking BiotechOct 23, 2026 - Oct 21, 2026
Data centers revive towns while corporate power concentratesMarketplaceOct 21, 2026 - Oct 21, 2026
Netflix faces an engagement test as capital costs stay highBrew MarketsOct 21, 2026 - Oct 21, 2026
Musk’s merger pitch tests Tesla’s next strategic frontierBloomberg IntelligenceOct 21, 2026 - Oct 21, 2026
SpaceX surges as Netflix and Abbott face investor pressureStock MoversOct 21, 2026 - Oct 21, 2026
AI demand lifts Supermicro as SpaceX merger speculation swirlsStock MoversOct 21, 2026 - Oct 21, 2026
AI demand lifts Supermicro as telecom and streaming stocks stumbleStock MoversOct 21, 2026 - Oct 17, 2026
Financial stress quietly taxes workplace performanceThe HCL Review PodcastOct 17, 2026 - Oct 11, 2026
Doctors challenge America’s processed-food health systemThe Megyn Kelly ShowOct 11, 2026 - Sep 23, 2026
A filmmaker turns nursing-home neglect into a reform movementTony Mantor: Why Not Me ?Sep 23, 2026 - Sep 14, 2026
AI safety fight collides with markets and midterm politicsWSJ What’s NewsSep 14, 2026 - Sep 12, 2026
Jones Day’s political network reshaped the federal judiciaryThe Daily BeansSep 12, 2026 - Aug 17, 2026
Cramer weighs memory-stock momentum against market volatilityMad Money w/ Jim CramerAug 17, 2026 - Aug 13, 2026
Cramer tests market expectations against company fundamentalsMad Money w/ Jim CramerAug 13, 2026 - Aug 11, 2026
How algorithms turn health anxiety into a marketThis Podcast Will Kill YouAug 11, 2026 - Jul 20, 2026
AI infrastructure sell-off tests investors’ convictionMad Money w/ Jim CramerJul 20, 2026 - Jul 16, 2026
Netflix slips on weak guidance while Abbott and Eli Lilly surgeStock MoversJul 16, 2026 - Jul 16, 2026
Abbott Laboratories raises guidance as JB Hunt and GH Research climbStock MoversJul 16, 2026 - Jul 16, 2026
Mixed earnings forecasts trigger sharp stock swings for major market playersStock MoversJul 16, 2026 - Jul 15, 2026
Cramer demands proof for AI’s next spending surgeMad Money w/ Jim CramerJul 15, 2026 - Jul 3, 2026
Legal victories and guidance resets trigger major swings in European stocksStock MoversJul 3, 2026